Research output per year
Research output per year
Description
Trial Name: TRial of Atorvastatin for the primary prevention of Cardiovascular Events in Rheumatoid Arthritis
Trial Description: Multi-centre, randomised, double blind, placebo-controlled trial
Background: Rheumatoid Arthritis (RA) is a severe, progressive disorder associated with increased and premature cardiovascular mortality. This study aims to assess if the statin Atrovastin will protect RA patients from atherosclerotic events.
Main Outcomes: To determine the effects of Atrovastatin on cardiovascular events and mortality in RA patients.
Patients recruited: 3808
Status: Completed
ISRCTN number: 41829447
Contact [email protected]
Trial Description: Multi-centre, randomised, double blind, placebo-controlled trial
Background: Rheumatoid Arthritis (RA) is a severe, progressive disorder associated with increased and premature cardiovascular mortality. This study aims to assess if the statin Atrovastin will protect RA patients from atherosclerotic events.
Main Outcomes: To determine the effects of Atrovastatin on cardiovascular events and mortality in RA patients.
Patients recruited: 3808
Status: Completed
ISRCTN number: 41829447
Contact [email protected]
| Date made available | 2023 |
|---|---|
| Publisher | University of Dundee |
| Date of data production | 2007 - |
Research output
- 2 Article
-
A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis: A multicenter, randomized, placebo controlled trial
TRACE RA consortium, Kitas, G. D. (Lead / Corresponding author), Nightingale, P., Armitage, J., Sattar, N., Belch, J. J. F. & Symmons, D. P. M., Sept 2019, In: Arthritis and Rheumatology. 71, 9, p. 1437-1449 13 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile85 Citations (Scopus)157 Downloads (Pure) -
Trial of Atorvastatin for the primary prevention of cardiovascular events in patients with RA (TRACE RA): A randomised trial in 2986 RA patients
Belch, J., 20 Apr 2015, In: Rheumatology. 54, Supplement 1, p. i87 1 p., 094.Research output: Contribution to journal › Article › peer-review